Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

Recruiting

Phase 1

InfliximabIntravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)

Sponsor:

Retina Research Foundation

Code:

NCT00695682

Conditions

Diabetic Retinopathy

Macular Degeneration

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

intravitreal injection of infliximab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-27. This information was provided to ClinicalTrials.gov by Retina Research Foundation on 2008-06-12.